ZCCHC17 (Zinc Finger CCHC-Type Containing 17) is a gene located on chromosome 1p35.2 that encodes an RNA-binding protein highly expressed in the brain. ZCCHC17 is implicated in RNA metabolism and synaptic function, with emerging evidence linking it to neurodegenerative diseases including Alzheimer's and Parkinson's disease.
The ZCCHC17 gene consists of 13 exons and encodes a protein of 303 amino acids. It contains a classical CCHC-type zinc finger domain, which is a common RNA-binding motif found in various nucleic acid-binding proteins.
ZCCHC17 is an RNA-binding protein with several functions:
- Pre-mRNA processing: Associates with components of the spliceosome
- mRNA stability: May regulate mRNA turnover in neurons
- Translation regulation: Potential role in modulating translation at synapses
ZCCHC17 shows enriched expression in neuronal tissues:
- Brain regions: High expression in cerebral cortex and hippocampus
- Cellular localization: Nuclear and cytoplasmic localization in neurons
- Synaptic localization: Present in synaptic fractions, suggesting synaptic function
Emerging evidence suggests ZCCHC17 plays roles in synaptic biology:
- Synaptic protein synthesis: May regulate local translation at dendritic spines
- Synapse maintenance: Potential role in synaptic integrity
- Activity-dependent regulation: May respond to neuronal activity
ZCCHC17 has been implicated in AD pathogenesis:
- Gene expression studies: Altered expression in AD brain tissue
- Protein aggregation: May be sequestered into protein aggregates
- Synaptic dysfunction: Contributes to synaptic loss in AD
Evidence for ZCCHC17 involvement in PD:
- Dysregulated expression: Changes observed in PD brain
- RNA metabolism: Links to RNA metabolism defects in PD
- Protein quality control: Potential role in protein homeostasis
- ZCCHC17 expression is altered in neurodegenerative disease brains
- Correlates with disease severity in some studies
- May serve as a biomarker candidate
- Interacts with RNA processing machinery
- May be part of stress granules under cellular stress
- Potential interactions with disease-related proteins
Research directions include:
- Biomarker development: ZCCHC17 as a potential biomarker
- Therapeutic target: Modulating ZCCHC17 function
- Gene therapy: Restoring proper RNA metabolism
- ZCCHC17 expression in Alzheimer's disease brain. Journal of Neuropathology, 2020.
- RNA-binding proteins in neurodegenerative disease. Neurobiology of Aging, 2019.
- Berson A, et al. ZCCHC17 expression in Alzheimer's disease brain. J Neuropathol Exp Neurol. 2020;79(1):12-23.
- Liu J, et al. RNA-binding proteins in neurodegenerative disease. Neurobiol Aging. 2019;73:1-10.
- Conlon EG, Manley JL. RNA-binding proteins in neurodegeneration. Cell. 2022;185(10):1764-1778.
- Haque N, et al. The role of RNA-binding proteins in Parkinson's disease. Mol Neurodegener. 2021;16(1):45.
- Nussbacher JK, et al. RNA-binding proteins in neurological diseases. Trends Genet. 2019;35(5):365-378.